Artigo Acesso aberto Revisado por pares

Use of Electrochemical DNA Biosensors for Rapid Molecular Identification of Uropathogens in Clinical Urine Specimens

2006; American Society for Microbiology; Volume: 44; Issue: 2 Linguagem: Inglês

10.1128/jcm.44.2.561-570.2006

ISSN

1098-660X

Autores

Joseph C. Liao, Mitra Mastali, Vincent Gau, Marc A. Suchard, Annette K. Møller, David A. Bruckner, Jane T. Babbitt, Yang Li, Jeffrey Gornbein, Elliot M. Landaw, Edward R.B. McCabe, Bernard M. Churchill, David A. Haake,

Tópico(s)

Molecular Biology Techniques and Applications

Resumo

ABSTRACT We describe the first species-specific detection of bacterial pathogens in human clinical fluid samples using a microfabricated electrochemical sensor array. Each of the 16 sensors in the array consisted of three single-layer gold electrodes—working, reference, and auxiliary. Each of the working electrodes contained one representative from a library of capture probes, each specific for a clinically relevant bacterial urinary pathogen. The library included probes for Escherichia coli , Proteus mirabilis , Pseudomonas aeruginosa , Enterocococcus spp., and the Klebsiella-Enterobacter group. A bacterial 16S rRNA target derived from single-step bacterial lysis was hybridized both to the biotin-modified capture probe on the sensor surface and to a second, fluorescein-modified detector probe. Detection of the target-probe hybrids was achieved through binding of a horseradish peroxidase (HRP)-conjugated anti-fluorescein antibody to the detector probe. Amperometric measurement of the catalyzed HRP reaction was obtained at a fixed potential of −200 mV between the working and reference electrodes. Species-specific detection of as few as 2,600 uropathogenic bacteria in culture, inoculated urine, and clinical urine samples was achieved within 45 min from the beginning of sample processing. In a feasibility study of this amperometric detection system using blinded clinical urine specimens, the sensor array had 100% sensitivity for direct detection of gram-negative bacteria without nucleic acid purification or amplification. Identification was demonstrated for 98% of gram-negative bacteria for which species-specific probes were available. When combined with a microfluidics-based sample preparation module, the integrated system could serve as a point-of-care device for rapid diagnosis of urinary tract infections.

Referência(s)